View Document Preview and Link Document Date: 2013-10-11 05:50:15 Open Document File Size: 121,89 KB Share Result on Facebook
City London / / Company Bayer Pharma AG / Overdose Management / AEs / PRAC / / Country United Kingdom / / Currency pence / / / Event FDA Phase / / Facility Canary Wharf / / IndustryTerm stroke prevention / food-drug interaction / Venous Thromboembolic Disease Treatment / medicinal product / food intake / Prevention of stroke / transporter systems / medicinal products / food / / MedicalCondition systemic embolism / vascular aneurysms / stroke / oesophageal varices / non-valvular atrial fibrillation / deep vein thrombosis / spinal injury / venous thromboembolism / Atrial Fibrillation Any CYP3A4 / pulmonary embolism / atrial fibrillation / arteriovenous malformations / malignant neoplasms / / MedicalTreatment invasive procedure / catheter / orthopaedic surgery / hip surgery / invasive procedures / knee surgery / surgery / / Organization European Medicines Agency / Committee for Medicinal Products for Human Use / European Union / E-mail info@ema.europa.eu Website www.ema.europa.eu An / / / Position physician / treating physician / Major / / Product phenytoin / Xarelto tablets / itraconazole / verapamil hydrochloride / Cyclosporine / carbamazepine / ketoconazole / clarithromycin / erythromycin / Xarelto / CYP3A4 / / RadioStation Core / / Technology pharmacokinetics / DUS / / URL www.ema.europa.eu / / SocialTag 
27 June[removed]EMA[removed]